Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

ClinicalTrials.gov ID: NCT00433381

Public ClinicalTrials.gov record NCT00433381. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 6:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized phase II trial is studying the side effects and how well giving bevacizumab together with irinotecan or temozolomide works in treating patients with recurrent or refractory glioblastoma multiforme or gliosarcoma. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor. Drugs used in chemotherapy, such as irinotecan and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving bevacizumab together with irinotecan or temozolomide may kill more tumor cells.

Study identification

NCT ID
NCT00433381
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
123 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2007
Primary completion
Jan 20, 2010
Completion
Feb 15, 2011
Last update posted
Sep 16, 2018

2007 – 2011

United States locations

U.S. sites
93
U.S. states
29
U.S. cities
76
Facility City State ZIP Site status
Mobile Infirmary Medical Center Mobile Alabama 36607
Fairbanks Memorial Hospital Fairbanks Alaska 99701
Arizona Oncology Services Foundation Scottsdale Arizona 85260
Alta Bates Summit Medical Center-Herrick Campus Berkeley California 94704
Mills-Peninsula Medical Center Burlingame California 94010
John Muir Medical Center-Concord Campus Concord California 94520
City of Hope Comprehensive Cancer Center Duarte California 91010
Marin General Hospital Greenbrae California 94904
Sutter Cancer Research Consortium Novato California 94945
California Pacific Medical Center-Pacific Campus San Francisco California 94115
Sutter Solano Medical Center/Cancer Center Vallejo California 94589
John Muir Medical Center-Walnut Creek Walnut Creek California 94598
Yale University New Haven Connecticut 06520
Boca Raton Regional Hospital Boca Raton Florida 33486
University of Florida Health Science Center - Gainesville Gainesville Florida 32610
Saint Luke's Mountain States Tumor Institute Boise Idaho 83712
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637
Saint Vincent Anderson Regional Hospital/Cancer Center Anderson Indiana 46016
Franciscan Saint Francis Health-Beech Grove Beech Grove Indiana 46107
IU Health Methodist Hospital Indianapolis Indiana 46202
Reid Health Richmond Indiana 47374
University of Iowa/Holden Comprehensive Cancer Center Iowa City Iowa 52242
Anne Arundel Medical Center Annapolis Maryland 21401
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109
Henry Ford Hospital Detroit Michigan 48202
Borgess Medical Center Kalamazoo Michigan 49001
Bronson Methodist Hospital Kalamazoo Michigan 49007
West Michigan Cancer Center Kalamazoo Michigan 49007
William Beaumont Hospital-Royal Oak Royal Oak Michigan 48073
Fairview Ridges Hospital Burnsville Minnesota 55337
Mercy Hospital Coon Rapids Minnesota 55433
Fairview-Southdale Hospital Edina Minnesota 55435
Unity Hospital Fridley Minnesota 55432
Minnesota Oncology Hematology PA-Maplewood Maplewood Minnesota 55109
Abbott-Northwestern Hospital Minneapolis Minnesota 55407
North Memorial Medical Health Center Robbinsdale Minnesota 55422
Park Nicollet Clinic - Saint Louis Park Saint Louis Park Minnesota 55416
United Hospital Saint Paul Minnesota 55102
Ridgeview Medical Center Waconia Minnesota 55387
Minnesota Oncology Hematology PA-Woodbury Woodbury Minnesota 55125
Washington University School of Medicine St Louis Missouri 63110
Northern Rockies Radiation Oncology Center Billings Montana 59101
Cheshire Medical Center-Dartmouth-Hitchcock Keene Keene New Hampshire 03431
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756
John F Kennedy Medical Center Edison New Jersey 08818
New Mexico Oncology Hematology Consultants Albuquerque New Mexico 87109
Memorial Sloan-Kettering Cancer Center New York New York 10065
Highland Hospital Rochester New York 14620
University of Rochester Rochester New York 14642
Mission Hospital-Memorial Campus Asheville North Carolina 28801
Carolinas Medical Center/Levine Cancer Institute Charlotte North Carolina 28203
Akron General Medical Center Akron Ohio 44307
Grandview Hospital Dayton Ohio 45405
Good Samaritan Hospital - Dayton Dayton Ohio 45406
Miami Valley Hospital Dayton Ohio 45409
Samaritan North Health Center Dayton Ohio 45415
Dayton NCI Community Oncology Research Program Dayton Ohio 45420
Veteran Affairs Medical Center Dayton Ohio 45428
Blanchard Valley Hospital Findlay Ohio 45840
Atrium Medical Center-Middletown Regional Hospital Franklin Ohio 45005-1066
Kettering Medical Center Kettering Ohio 45429
Upper Valley Medical Center Troy Ohio 45373
Greene Memorial Hospital Xenia Ohio 45385
Legacy Mount Hood Medical Center Gresham Oregon 97030
Providence Milwaukie Hospital Milwaukie Oregon 97222
Legacy Good Samaritan Hospital and Medical Center Portland Oregon 97210
Providence Portland Medical Center Portland Oregon 97213
Adventist Medical Center Portland Oregon 97216
Providence Saint Vincent Medical Center Portland Oregon 97225
Legacy Emanuel Hospital and Health Center Portland Oregon 97227
Legacy Meridian Park Hospital Tualatin Oregon 97062
Radiation Therapy Oncology Group Philadelphia Pennsylvania 19103
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
Rhode Island Hospital Providence Rhode Island 02903
M D Anderson Cancer Center Houston Texas 77030
American Fork Hospital / Huntsman Intermountain Cancer Center American Fork Utah 84003
Sandra L Maxwell Cancer Center Cedar City Utah 84720
Cottonwood Hospital Medical Center Murray Utah 84107
Intermountain Medical Center Murray Utah 84107
McKay-Dee Hospital Center Ogden Utah 84403
Utah Valley Regional Medical Center Provo Utah 84604
Intermountain Health Care Salt Lake City Utah 84103
Utah Cancer Specialists-Salt Lake City Salt Lake City Utah 84106
LDS Hospital Salt Lake City Utah 84143
Dixie Medical Center Regional Cancer Center St. George Utah 84770
Norris Cotton Cancer Center-North Saint Johnsbury Vermont 05819
Saint Francis Hospital Federal Way Washington 98003
EvergreenHealth Medical Center Kirkland Washington 98033
Virginia Mason Medical Center Seattle Washington 98101
University of Washington Medical Center Seattle Washington 98195
PeaceHealth Southwest Medical Center Vancouver Washington 98664
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792
Froedtert and the Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00433381, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 16, 2018 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00433381 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →